|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBOOKCENTRAL_on1347023460 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr cnu|||||||| |
| 008 |
230209s2006 xx o ||| 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|c EBLCP
|d OCLCQ
|d EBLCP
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCL
|d OCLCQ
|
| 020 |
|
|
|a 9780470987261
|
| 020 |
|
|
|a 047098726X
|
| 035 |
|
|
|a (OCoLC)1347023460
|
| 082 |
0 |
4 |
|a 615.1
|q OCoLC
|2 23/eng/20230216
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Griffin, John P.
|
| 245 |
1 |
4 |
|a The Textbook of Pharmaceutical Medicine
|h [electronic resource].
|
| 260 |
|
|
|a Newark :
|b John Wiley & Sons, Incorporated,
|c 2006.
|
| 300 |
|
|
|a 1 online resource (882 p.).
|
| 490 |
1 |
|
|a New York Academy of Sciences Ser.
|
| 500 |
|
|
|a Description based upon print version of record.
|
| 505 |
0 |
|
|a The Textbook of Pharmaceutical Medicine -- Contents -- Contributors -- Preface -- Acknowledgements -- The Editors -- PART I: Research and development -- 1. Discovery of new medicines -- 2. Pharmaceutical development -- 3. Preclinical safety testing -- 4. Exploratory development -- 5. Clinical pharmacokinetics -- 6. Purpose and design of clinical trials -- 7. Conduct of clinical trials: good clinical practice -- 8. Medical statistics -- 9. Development of medicines: full development -- PART II: Medical department issues -- 10. The medical department -- 11. Medical marketing
|
| 505 |
8 |
|
|a 12. Information and promotion -- 13. The supply of unlicensed medicines for particular patient use -- 14. Legal and ethical issues relating to medicinal products -- 15. The safety of medical products -- PART III: Regulatory aspects -- 16. History of drug egulation in the United Kingdom -- 17. Regulation of human medicinal products in the European Union -- 18. European regulation of medical devices -- 19. Technical requirements for registration of pharmaceuticals for human use: the ICH process -- 20. The regulation of drug products by the United States Food and Drug Administration
|
| 505 |
8 |
|
|a 21. The US FDA in the drug development,evaluation and approval process -- 22. Past evolution and future prospects of the Pharma Industry and its regulation in the USA -- 23. Regulatory and clinical trial systems in Japan -- 24. The regulation of therapeutic products in Australia -- PART IV: Pharmacoeconomic and other issues -- 25. Economics of healthcare -- 26. Controls on NHS medicines prescribing and expenditure in the UK (a historical perspective) with some international comparisons -- Appendix 1: Declaration of Helsinki -- Appendix 2: Code of Practice for the Pharmaceutical Industry
|
| 505 |
8 |
|
|a Appendix 3: Guidelines and Documentation for Implementation of Clinical Trials -- Appendix 4: Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 -- Index
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 655 |
|
0 |
|a Electronic books.
|
| 758 |
|
|
|i has work:
|a The textbook of pharmaceutical medicine (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCH4QQ6bpxcXWmKMFrcGHyd
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Griffin, John P.
|t The Textbook of Pharmaceutical Medicine
|d Newark : John Wiley & Sons, Incorporated,c2006
|z 9780727918406
|
| 830 |
|
0 |
|a New York Academy of Sciences Ser.
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=7103399
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL7103399
|
| 994 |
|
|
|a 92
|b IZTAP
|
